Churchill Financial Advisors LLC Acquires New Holdings in Corteva, Inc. $CTVA

Churchill Financial Advisors LLC acquired a new stake in Corteva, Inc. (NYSE:CTVA) during the fourth quarter, HoldingsChannel.com reports. The institutional investor acquired 11,797 shares of the company’s stock, valued at approximately $791,000.

Other large investors have also recently added to or reduced their stakes in the company. Activest Wealth Management grew its stake in Corteva by 118.3% in the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after acquiring an additional 200 shares during the last quarter. JPL Wealth Management LLC acquired a new stake in Corteva in the 3rd quarter valued at about $25,000. Redmont Wealth Advisors LLC acquired a new stake in Corteva in the 3rd quarter valued at about $29,000. Jackson Grant Investment Advisers Inc. grew its stake in Corteva by 90.6% in the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock valued at $30,000 after acquiring an additional 213 shares during the last quarter. Finally, KERR FINANCIAL PLANNING Corp acquired a new stake in Corteva in the 3rd quarter valued at about $33,000. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Trading Up 0.0%

NYSE CTVA opened at $79.57 on Monday. Corteva, Inc. has a one year low of $60.53 and a one year high of $85.63. The company’s 50 day moving average price is $81.33 and its 200 day moving average price is $74.04. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The firm has a market capitalization of $53.22 billion, a price-to-earnings ratio of 46.81, a PEG ratio of 2.43 and a beta of 0.59.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same quarter last year, the firm posted $1.13 earnings per share. Corteva’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts predict that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be issued a $0.18 dividend. The ex-dividend date is Monday, June 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 42.35%.

Analysts Set New Price Targets

CTVA has been the topic of a number of research reports. Jefferies Financial Group increased their price objective on shares of Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. UBS Group upped their target price on shares of Corteva from $88.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Royal Bank Of Canada upped their target price on shares of Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. Wall Street Zen lowered shares of Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Finally, JPMorgan Chase & Co. lowered shares of Corteva from an “overweight” rating to a “neutral” rating and upped their target price for the company from $75.00 to $77.00 in a report on Thursday, February 5th. Thirteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and an average target price of $88.14.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.